CervoMed Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CervoMed Inc. stock issued during period, value, issued for services for the quarter ending 2024-12-31 was $0.00.
- CervoMed Inc. stock issued during period, value, issued for services for the quarter ending 2024-09-30 was $0.00.
- CervoMed Inc. stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $0.00.
- CervoMed Inc. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $255.72K.
- CervoMed Inc. stock issued during period, value, issued for services for fiscal 2024 was $255.72K.
- CervoMed Inc. stock issued during period, value, issued for services for fiscal 2022 was $127.52K.
- CervoMed Inc. stock issued during period, value, issued for services for fiscal 2018 was $50.00K, a 0.00% change from fiscal 2017.
- CervoMed Inc. stock issued during period, value, issued for services for fiscal 2017 was $50.00K, a 96.45% decline from fiscal 2016.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $255.72K 10-K · filed 2026-03-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | |
| 2024-03-31 | $255.72K 10-Q · filed 2025-05-12 | |
| 2022-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $127.52K 10-K · filed 2024-03-29 |
| 2018-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $50.00K 10-K · filed 2020-03-17 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | |
| 2018-06-30 | $25.00K 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $50.00K 10-K · filed 2019-03-19 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.41M 10-K · filed 2018-04-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2016-06-30 | $921.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | |
| 2016-03-31 | $487.50K 10-Q · filed 2016-05-16 | |
| 2013-12-31 | $10.50K 10-K/A · filed 2014-04-23 | |
| 2012-12-31 | $1.59M 10-K/A · filed 2014-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |